Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.9400 (-2.24%) ($13.8500 - $13.9400) on Mon. Aug. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.34% (three month average) | RSI | 44 | Latest Price | $13.9400(-2.24%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BCRX declines -0.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(33%) VT(32%) VUG(32%) BLOK(30%) URA(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.17% in a week (0% probabilities). VIXM(-16%) UUP(-14%) SMH(-10%) EDOC(-6%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.17% (StdDev 4.34%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $14.07 | 5 Day Moving Average | $14.46(-3.6%) | 10 Day Moving Average | $14.35(-2.86%) | 20 Day Moving Average | $14.07(-0.92%) | To recent high | -5.9% | To recent low | 53.4% | Market Cap | $2.459b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |